The mass spectrometry laboratory is the first lab Scinovo established. The lab uses mass spectrometry as the detection platform. The platform has a total of 11 liquid mass spectrometers (Triple 5500, Triple Quad 4500, API 4000 of AB Sciex). We can provide a full range of services such as method development, analytical method transfer, analytical method verification, multiple matrix sample analysis and metabolite identification, and provide accurate and high-quality biological analysis data for drug development.

The work that the mass spectrometry laboratory can carry out includes:

1. Non-clinical DMPK studies, including drug metabolism, toxicokinetics, tissue distribution, drug excretion, metabolite identification, metabolite stability studies, etc..

2. Bioequivalence research, including: development and validation of bioanalytical methods, sample testing, and documentation that meets the requirements of new drug application.

3. Clinical pharmacokinetic research, including: assisting in the design of clinical programs, clinical biological sample analysis, drug-drug interaction, etc..